Provided by Tiger Trade Technology Pte. Ltd.

Voyager Therapeutics

3.53
-0.1000-2.75%
Post-market: 3.530.00000.00%17:26 EDT
Volume:362.77K
Turnover:1.30M
Market Cap:213.27M
PE:-1.78
High:3.67
Open:3.66
Low:3.52
Close:3.63
52wk High:5.55
52wk Low:2.83
Shares:60.42M
Float Shares:39.77M
Volume Ratio:0.75
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9799
EPS(LYR):-1.1272
ROE:-52.26%
ROA:-27.05%
PB:1.23
PE(LYR):-3.13

Loading ...

Voyager Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Voyager Q1 net loss narrows to $27.9 million; revenue drops to $2.6 million

Reuters
·
May 08

BRIEF-Voyager Therapeutics Q1 Collaboration Revenue USD 2.593 Million

Reuters
·
May 08

Voyager Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
May 01

H.C. Wainwright Reaffirms Their Buy Rating on Voyager Therapeutics (VYGR)

TIPRANKS
·
Apr 29

Voyager plans IND filing for Alzheimer’s gene therapy VY1706 in Q2 2026

Reuters
·
Apr 28

BRIEF-Voyager Therapeutics Inc - Nathan Jorgensen Resigns As CFO Effective May 8, 2026

Reuters
·
Apr 22

Voyager Therapeutics Announces CFO Resignation and Finance Leadership Changes

TIPRANKS
·
Apr 22

Voyager Therapeutics Inc - Nathan Jorgensen Resigns as CFO Effective May 8, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 22

CORRECTED-Amazon launches AI research tool to speed early-stage drug discovery

Reuters
·
Apr 14

Voyager Therapeutics management to meet with Oppenheimer

TIPRANKS
·
Apr 11

Voyager Therapeutics announces annual shareholder meeting agenda includes authorized share increase vote

Reuters
·
Apr 11

Top Executive at Voyager Therapeutics Makes Notable Stock Move

TIPRANKS
·
Apr 04

Voyager Therapeutics: Early-Stage Tau Program Optionality Drives High-Risk, High-Upside Buy Rating

TIPRANKS
·
Mar 24

Voyager Therapeutics Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 18

Voyager Therapeutics: Differentiated CNS Platform, Strategic Partnerships, and 2026 Data Catalysts Underpin Buy Rating

TIPRANKS
·
Mar 18

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
Mar 17

Voyager Therapeutics: Advancing Tau-Targeted Gene Therapy with Multiple Near-Term Catalysts and Attractive Risk-Reward

TIPRANKS
·
Mar 12

Guggenheim Remains a Buy on Voyager Therapeutics (VYGR)

TIPRANKS
·
Mar 11

Voyager Therapeutics Faces Rising Tariff and U.S.–China Geopolitical Risks as BIOSECURE Act Threatens Key Chinese CDMO Partnerships

TIPRANKS
·
Mar 11